Placeholder Image

Subtitles section Play video

  • greetings and welcome to a special edition of the University of Minnesota alumni associations.

  • Webinar Siri's My name is John Reject, and I'm the senior director of alumni networks for the Alumni Association.

  • Thank you to all alumni and friends who have made time to join us live today.

  • Today's Webinar, a Citizen's Guide to Ebola, is presented by one of the world's most sought after experts on infectious disease threats in international health.

  • Dr Michael Foster, home of the University of Minnesota, who will give an overview of key aspects of the Ebola epidemic and what the public really needs to know.

  • This webinar is part of a new free Siri's being offered by the University of Minnesota Alumni Association, where we're having conversations with experts about career life in learning topics.

  • The webinar is being recorded and will be viewable afterwards at Minnesota Alumni Dot or GE Backslash alumni Webinar Siris Just give us a few business days toe posted on our website, and we'll also send a reminder email to participants who are joining us today.

  • And if you're on Twitter right now, tweet at us with the hashtag you m and webinar.

  • We'd love to hear from you.

  • You can also follow.

  • Ah, the University of Minnesota Center for Infectious Disease Research and Policy said.

  • Rap on Twitter.

  • You see there handle there as well Before we get started.

  • Let's go over a few items so you know how to best participate in today's event.

  • You have joined the presentation listening.

  • You're listening using your computer speakers by default.

  • If you'd prefer to listen over the telephone, just select telephone in the audio pain of your Goto weapon.

  • Our panel and island information will be displayed if you experience audio difficulties while listening via your computer speakers.

  • This can be caused by having multiple software applications open, which can use up your computer's band with an effect network performance.

  • So feel free to close any unnecessary applications on your computer at this time.

  • Questions are welcome, and you may submit them at any time police type in your questions and the questions pain on your goto weapon.

  • Our control panel.

  • We'll track questions along the way, and our presenter will leave time near the end of the webinar two addresses many questions as we have time for.

  • It's now my pleasure to welcome to the Webinar Dr Michael Foster home.

  • Dr.

  • Auster Home is the McKnight presidential endowed chair in public health at the University of Minnesota and director of the Center for Infectious Disease Research and Policy.

  • He's also a professor in the division of Environmental Health Sciences at the School.

  • Public Health.

  • A professor in the Technological Leadership Institute in the College of Science and Engineering in an adjunct professor in the medical school here at the University of Minnesota.

  • He is also a member of the Institute of Medicine off the National Academy of Sciences in the Council of Foreign Relations.

  • Dr.

  • Auster Home is the author of more than 315 papers and abstracts, including 21 book chapters, and is a frequently invited guest lecturer on the topic of epidemiology of infectious diseases.

  • He has received numerous honors for his work and has been the recipient of six major research awards from the N.

  • I.

  • H and the CDC.

  • We're very honored that he's taken time out of his busy schedule to join us today.

  • Welcome to the weapon, our Dr Foster home.

  • Thank you very much and thank you for having me today over the next 45 to 50 minutes, I will share with you an overview of what one might call a citizen's guide to the Ebola epidemic.

  • And in doing that, I hope that I will be able to provide some constructive comments about where we're at and where we're going.

  • First of all, let me just say I have no financial relationships to disclose here, and I also do not, uh, will not discuss sending off label or investigations from my presentation.

  • And I know less about Ebola today than I did six months ago.

  • So please take that information provided here with that acknowledgement to start out, let me just come into and two quotes, I think, really set the overall stage room talk about today.

  • One is from Daniel Bornstein, former librarian to Congress, once said, the greatest obstacle is discovering the shape of the Earth, the continents and the oceans was not ignorance with the illusion of knowledge.

  • I think you'll see today that we can safely say that we're learning a lot about Ebola is a virus as an infectious disease and as a interface with global public health practice in medical care, and we have a lot more to learn second ball.

  • Richard Feinman, the former Nobel Prize laureate, one said, For a successful technology, reality must take precedence over public relations, for nature cannot be full.

  • I think we can also add here that for a successful public health intervention, reality must take presidents, and we're learning a great deal in that regard.

  • Now the next slide is really a context slide that shares with you a sense of how and why we might be concerned about Ebola in a different way today than we have in the past.

  • As you see here, you can see how world population has increased from 18 50 to 2000 today at about 7.5 billion people wanted.

  • Every eight people who's lived is on the face of the earth right now.

  • In addition, of course, global trade and travel.

  • While the time hasn't gotten any faster to get around the world since 19 fifties, the amount of people goods items of the things that go around the world hat these two factors of really combined to make for a potential for Ebola today, too, do things that from a public health perspective that we had not really once considered for example, one of the areas of the fastest growing growth in human population is actually in the equatorial belt of Africa with the new mega cities there, and this is clearly an important aspect of what's happened in terms of the recent months in West Africa.

  • Now to give a basic background on the Ebola virus in human infection was named after the Ebola River and what was then Zaire now the Democratic Republic of the Congo was first discovered in 1976 in a very remote rural village area.

  • Since that time, there have been 24 outbreaks are isolated case occurrences documented, of which 20 of these were community white outbreaks.

  • So in a sense, very limited, likely before 1976 such outbreaks also occurred.

  • But because of the very sparse human population in Equatorial Africa, it's unlikely that any of these would have been large outbreaks where I'm going and sustaining when you look at the total number of people that were known to be.

  • Cases in these 20 outbreaks numbered about 2400.

  • Most of the transmission was extremely limited for the Ebola Sudan outbreak.

  • There was probably 15 different generations on that was it a generation being from person 12 person to his one generation person to person three.

  • But for the virus that we're dealing with today, Bhola, Zaire the most number of transmission generations was five.

  • And in this regard, uh, you can summarize, really by saying Ebola is hardly paying the human species before the current West Africa outbreak and really is an important context point again to understand what do we know and not know about this infection now, in terms of how Ebola virus is transmitted, this is an area that we know a lot about.

  • But if you could imagine our knowledge base for this is like a normal curve or 98% of the curve eyes fairly well known to us and something that we can describe with some and Chrissy clearly details, the 1% on either side of the curve is yet really unclear to us on.

  • We have things to learn about it so, but what we do know is that with direct contact from an effective person or animal body fluids including blood, vomit, feces and possibly perspiration is a the primary mechanism for transmission.

  • The current outbreaks highlighted questions about transmission, for example, Early on, we placed a great deal of emphasis on the presence or absence.

  • The fever will talk about that.

  • We'll talk briefly about the issue of what has been labeled airborne transmission on and also just the issue about worker safety.

  • Despite the recent interest in and concern about health care, worker transmission and safety here in the United States or you, we must understand that while these air important cases we must not take our eye off the ball, which is really about Africa.

  • And today this presentation will continue to highlight all the aspects of evil in Africa.

  • Now, I mentioned earlier, just as an example of the questions about what we know and don't know.

  • Here is a very nice review by the World Health Organization Bullet Response Team, published in the New England Journal of Medicine in mid October, summarizing the 1st 9 months of the epidemic with some kind of some comments on future projections.

  • One of the things to note here, despite this case definition requiring fever or else to be tested for Ebola virus and found positive, which would favor in fact, finding patients with fever on Lee, 87.1% of cases reported a fever throughout the course of their illness.

  • This is a point to make that we have to be very careful about absolutes.

  • And there have been, I think, a effort by many to do a better job of that early on in the public concern about Ebola, we did, as a public health community, make very absolute statements out of, I think, a obvious need to our desire to assure the public about various aspects of transmission.

  • Today.

  • We'll talk more about that as we realize that not everything is going to be in clear black, a wife if we look at the disease itself.

  • In this slide here, you can see the predominant symptoms of fever, fatigue, loss of appetite, vomiting and diarrhea.

  • You can also look at this more carefully for those who died and those who recovered.

  • But the point to make is the traditional viewed picture of Ebola, which was really put forward, and books like the hot zone, copious amounts of bleeding, bleeding out of the eyes and so forth is really not the case.

  • What we see here, if you look down blood and stool gums.

  • But he knows Buddy Cough it really is.

  • Just a few percent of those individuals is high.

  • It's 18% among the general number of cases.

  • What unexplained bleeding.

  • But generally it was very small.

  • What you're really doing with the disease presents primarily as a constellation of fatigue, loss of appetite, vomiting and diarrhea.

  • And these air the again, the symptoms today that along with fever, we would urge people to be a mindful of it.

  • Someone has developed an illness and have recent travel to West Africa, the affected countries or contact with someone who was there.

  • What do we know about Ebola virus?

  • Ecology?

  • Well, this is one that we still have lots of questions about.

  • One outbreak clearly was able to demonstrate that fruit that's where the source on.

  • And but beyond that, it's unclear exactly what the natural reservoir is for.

  • The Ebola virus is.

  • Goal is a year.

  • If you look at this very nice cartoon from the CDC, you can see this reservoir being portrayed as being bass and variable possible that that is the primary and on Lee Reservoir within transmission into other animal species called salve attic cycle And there you can see transmission, whether it be, uh, some human primates, bats and other animals, then getting to humans for contact with these animal species, most often usually around a food source exposure where someone who finds a dead animal or a sick animal on and then basically prepares that for a meal with contact occurring with the body fluids of that animal, we still have much to learn about this whole somatic cycle, where the virus resides in between the times when we don't have heaven had outbreaks.

  • We look at the belt here of where we're talking about countries with index reported cases in countries at risk without reported cases, you get a sense of looking at the rainforest and where we're looking at the potential for these cases.

  • West Africa, as we know the three primary effected countries today, shouldn't have been a surprise yet.

  • In a sense, they were because we had not seen in our sporting some your history Ebola virus transmission There.

  • We begin following this situation in March at our Center for Infectious Disease Research and Policy, recognizing that initially this seemed to be just another Ebola outbreak in this case, in a slightly different location in the equatorial belt.

  • But it became very clear.

  • Tow us at least early on that this was a different situation and a number of NGOs, particularly the Doctors Without Borders or MSF.

  • I made it very clear that they believe that this was different, that it wasn't being brought under control, using the same kind of public health intervention methods of identifying cases, quickly isolating them and medical care and following up context.

  • Now some of this clearly had to do with a lack of adequate response to due to the lack of public caliph in medical care infrastructure in the affected countries.

  • Also, it seemed as if something else was happening.

  • We look at this particular pictorial here, this cartoon in the right hand bottom, you can see the conjoining areas of Guinea, Sierra Leone and Liberia, where the outbreak first begin, and from there, then spread throughout the other three of the three countries throughout their entire area.

  • I wrote a piece actually in The Washington Post in late July, in which, uh, this was before the cases had occurred in were brought to the public's attention around American physicians brought home which would seem to be a a very important event in terms of highlighting the issue.

  • One of the things that you'll note in the second paragraph I started enforcement.

  • Today's outbreak is very different and trying to explain that this really did seem to be very, very different and what I hypothesize in this piece was it wasn't because the virus had changed because Africa changed and I'm not so sure that's the case today.

  • I think as we gain more information, we may see that this virus is slightly different in terms of its ability to cause disease on and such things as virus load or tighter and so forth.

  • But the bottom line is it did fall into a geographic area where the health and public health infrastructure were generally virtually nil to absent, and the fact that there was intense personal crowding in for a lack of a better term, the slums of the major cities in the rural area.

  • We also had some successes early on, and this is one of the things that has made this situation a bit more complicated in terms understanding.

  • If you look here again, the three of impacted cases but I want to highlight this slide because of their one case occurring in Senegal early on, as well as a case that was introduced into Nigeria.

  • Let me spend more time in the Nigerian situation where in fact an individual who is infected in Liberia flew to Lagos, Nigeria.

  • It occurred at a time when the public health care system was actually or the public health system was on strike.

  • And this individual is hospitalized actually in a private hospital which have provided and you sense a high level of care.

  • This was a good thing because of the fact that it really limited his contact and potential in a lack of adequate healthcare setting to be cared for.

  • The problem was, is that there still was transmission occurred in this setting.

  • And I think one of the really remarkable achievements so far to date was the combined effort of the Nigerian Health and Public Health Systems, along with the CDC toe actually limit and stop this I'm going chain of transmission.

  • It occurred again primarily in health care workers.

  • This outbreak required over 1000 people be followed up and I only show this because this slide has often been used in the story in Nigeria is an example of how we can still stop this in Africa.

  • I would suggest you do the same patient entered Nigeria but spent time in the slums of Lagos and was not detected early.

  • And there have been several generations the transmission, the outcome could have been very different.

  • We are seeing that today is we now actually have eight cases in Mali.

  • Hold the last two weeks of which we now are concerned about a new focus of transmission.

  • There s O that we recognize also the lack of preparedness.

  • Even though this is right on the border with getting this individual was able to move freely from Guinea, tamale actually was infected, then started this new chain of transmission Very similar effort that was, as was conducted with the individual uh, flew into Nigeria is being done here.

  • The question is, will it be able to be stopped here?

  • But it points out the vulnerability of the rest of Africa to what I call the infectious disease forest fire of the three affected countries, sending sparks throughout other areas of Africa in the world.

  • Now, in terms of understanding current case numbers.

  • These are the data from this week from the World Health Organization.

  • We all recognize there's been massive under reporting on again.

  • It just goes to speak to the functionality of the public health system there.

  • Today there have been 3 15,051 cases reported, 5459 deaths.

  • The transmission remains most intense in Guinea, Liberia, Sierra Leone, with more recent cases now eight cases.

  • Molly, We suspect that this may be our under reporting is by as much as three More recently.

  • It may be less than that.

  • So you may be talking about his many as 45,000 cases as many as almost 16,000 deaths.

  • It's unclear, but I think to put this into perspective, which, by the way, remember we had only 2400 cases total in all of the Ebola epidemics up to this point.

  • So it gives you some perspective.

  • But where are we going?

  • There have been a number of attempts to provide some estimate, and I show this slide it's only as of August, and it wanted intentionally to give you a sense of this early increase in cases which set the tone for how people made estimates for future case numbers in this very early window of just a few weeks.

  • We then extrapolated numbers, which were quite remarkable.

  • The debate has gone on and on about how many cases will there really be?

  • What does it matter what we don't have done or not have done with regard to public health and medical interventions?

  • In that same article I showed you earlier published in September, 23rd World Health Organization, based on their modeling, concluded that there may be as many as 20,000 cases in total by November 2nd.

  • Well, as reported cases go is, you know, that's not the case is 15,000.

  • If you look at unreported how you fact in this in because he's reported cases here, I actually think that this estimate is actually quite remarkably good in terms of the overall assessment of what was going on, However, the same like that that was published, the Sinister Disease Control and Prevention published an article suggesting that they extrapolated trips.

  • Trends to January 20 without additional interventions are changing behavior.

  • The model also estimates that Liberian Sierra Leone will have approximate $550,000 case is about 1.4 million corrected for under reporting.

  • This estimate, I can tell you having done a number of briefings in Washington, D.

  • C and elsewhere was a very important driving factor in people being extremely concerned about what Ebola might or might not do today.

  • We obviously are far, far under that number.

  • Recent explanations from the CDC have been that, in fact, because of activities primarily in Liberia, these numbers will not be met.

  • I think we just have to admit it that these numbers really were gross overestimate based on data that I think was unfortunately, very robust if one looks necessarily owned, which would have accounted for about half of these cases, remember, this is only two countries, not three countries necessarily own in Liberia.

  • We show could have expected upwards of 200 to 250,000 cases reported, and we're not gonna be anywhere close to that.

  • And Sierra Leone has not head major interventions in community behavior that could explain this issue.

  • I just point this out because this is going to be a credibility issue over the days to come.

  • I don't believe that anyone intentionally misled anyone into these higher numbers.

  • But we're going to be the public health community after addressed that we scared the hell out of people needlessly early on.

  • And I think this was, uh should be a sobering message to all of us about the need we need to take in how we report or project future cases.

  • My message has been for over two and 1/2 months.

  • There's gonna be lots and lots of cases and lots of months.

  • The deaths and I don't know what that number is, but I think we need to have more that honesty in terms of our presentations.

  • If one looks today.

  • These are the numbers from this recent W H O report with yellow dots and size representing the number of cases in the past 21 days, you can see the ongoing activity primarily in Sierra Leone, even continuing in Liberia.

  • All those is on a mission.

  • The moment the information in Liberia clearly does point to a reduced number of new cases and in some cases actually leveling off to reduction.

  • Another geographic carries Now what can explain that some have suggested it could made of the fact that people will not report or provide their dead to, uh, uh, the officials.

  • Because of the concern about mandatory information issue, I think this clearly cannot explain the reduction.

  • It may be in part, but there have been very clear, I think, in evident activities in Liberia to reduce transmission.

  • Um and and I give ah, the CDC a lot of credit here because they have been very much a part of that whole activity, and they've provided several nights documents that discussing that they're still.

  • However, as I pointed out that concern in Sierra Leone with new infection control chains continuing and as long as this is occurring in one country it can occur in any country, meaning that this is your only as good as basically your last days effort that if we let up the the accelerator of response that could see transmission clearly moved back out of areas that had previously had major activity than read reduced activity.

  • We know that from ongoing statements that this mixed picture is there, this is something that has been happening for some time, where you see activity and then you see it reduced.

  • This is an example here back from August, where Ginnie reopens the Ebola clinic is six bill over the border.

  • I have, like in this, in some cases, to what I call fireworks transmission, where up until at least the last month in Liberia, we've had examples of where there has been substantial activity than a period of reduced activity, which is unexplained.

  • Even in some cases, treatment units were actually reduced in size or moon because of the reduced activity, only to have to come back again.

  • Now we're hopeful that teeth reductions in library in terms of new cases is going to be sustainable.

  • But this is one we have to be very mindful.

  • Could this be a big flash with cases goes dark and we have another flash again, uh, this kind of fireworks transmission issue, or are we really sustaining the gains that we've made?

  • Ah, good example of the confusion that the public has is the confusion we in public health health.

  • This is the first of two articles published last Friday, November 20th in The New York Times.

  • You bow spread has slowed in Liberia, CDC says talks about the idea of the worst case projections are not gonna happen, which again, I've already made my comments about that.

  • But if you read this article, you would come away with the fact that they're still concerned.

  • But then, in fact, we've really made great progress.

  • Then that same day, another article published in New York Times, actually earlier in the day on the website and the print edition.

  • The next day, officials revised goals on containing U Boat after signs of wider exposure and mountain.

  • But if you read through this entire article, you come away with saying, Boy, this isn't quite as good as we think.

  • We've had a lot of work to do and I think these articles are both correct.

  • I think they reflect the ongoing differences we see in transmission by geographic area by time and by our efforts and one of the things, I think we're gonna have to become more comfortable with this uncertainty that generally speaking, we still have an upward growing operate in at least two of the three countries in one of the country's.

  • It's not clear yet what's going to happen, and in this sense we we cannot let our foot off the prevention and treatment accelerator.

  • We know that in some areas we've had shortages of beds that continue.

  • One of the areas that I raise this point here is because one of the things we're doing is we're going back and revisiting just what do we need to do?

  • Remember the mantra in August and early September with treatment, bed treatment, beds, treatment bets.

  • Now we have treatment centers with no one arriving for care, and one of the issues has been.

  • Do we need to reconsider where we do treatment in the community?

  • How we do it, Our Ebola treatment units really still the primary way?

  • And for a number of the areas, Yes.

  • But I think that one of the things this outbreak is doing this challenging our thinking about how do we do effective Ebola treatment to both improve patient outcome, but also to better impact on the public health aspects of the epidemic.

  • This is a article from today from BBC highlights and number ongoing problems we've had with infrastructure.

  • Their burial workers and sterile Leone have done bodies in public in protest of nonpayment of allowances.

  • We've had multiple strikes over recent weeks in Liberia, Inserra Leone by workers.

  • We're not being paid or lacked adequate protective equipment, and this makes it very hard.

  • Thio move forward with our prevention efforts if we don't have sufficient either support of our national health care workers and or their protection again, another challenge, what we're talking about.

  • So to sum it up, let's just be very clear.

  • The global leader is you.

  • And in John Secretary General, the director general of secretary general of the World Health Organization, Others have been clear and compelling in their message about the need to keep our eye and West African.

  • Why that's important.

  • I think this is another area where CDC played a very key role early on, trying to highlight the importance of West African why we need to keep our eye on that area and our response really isolated in a sense, to that area.

  • Right now, we know we're not going to meet the deadlines that were originally suggested by the U.

  • N for 70% of cases being treated and ensuring 70% of safe burials by December 1st, this part of the issue in Sierra Leone progress in Liberia has been Maur, but again, recent reported outbreaks and scattered villages out throughout Liberia raised questions about that.

  • I've actually been in contact today with multiple colleagues in these countries in West Africa, all reaffirming the amazing and incredible challenges store before us in terms of trying to stop transmission in many of these areas.

  • One point I would like to make is that there's been much made about what we know about this virus and making the assumption that it hasn't changed or this is gonna happen.

  • This remains the primary publication, although recently Southers have raised questions about it.

  • It really a lucid eight's, the genetic status of the virus in one localized village city area of Sierra Leone from May.

  • And it really calls the question why we don't have more information in our current scientific repertoire in terms of what's happening with the virus and AA meeting held at the National Gallery sentence to the medicine several weeks ago on research needs, Free bowl highlighted the urgent need Thio obtain more virus isolate samples.

  • This is a complicated area, working with national governments, local organizations on the ground and international organizations to get this information.

  • But right now, anyone who tells you they know what this virus is all about genetically or otherwise really are missing the boat.

  • We have major questions here about this.

  • Yet early on there were lots of discussions about the inadequate response and why we had not done a better job with quickly recognizing this in the August 28th World Health Organization Evil a roadmap which was first laid out of response, which some very quickly became outdated because of the overwhelming outbreak.

  • Just blowing right by many of the points of this substance doing an article is published in which Ws Mrs Bosch is early attempt to stop the disease is the headline read here.

  • This report has not yet been released.

  • My point is take a step back, everyone You know, no one really is at fault for having missed the early signs and been able to do the kind of critical early work because everybody did.

  • I don't care what country you're in.

  • I don't care what government you work for.

  • What private agency, uh are in terms of international.

  • We really do have a critical issue here in terms of, uh, how we responded.

  • And this is going to be something we need to look at very carefully for the future in terms of how we respond and lessons weren't is going to be important.

  • But now is not the time to point fingers at anyone at all.

  • One of the areas that I remain very concerned about is the ability to recruit ongoing health care workers.

  • We may be able to build more beds.

  • We need all the Biltmore treatment units were able to do a lot of things that are all in the right direction.

  • But if we don't have the skilled health care workers both nationally and internationally, too, uh, provide that kind of care and follow up, we're in trouble.

  • And I think right now this is a very what I call a difficult time in terms of one.

  • We're in the fog of war, where it's unclear what's going on, and some people are perceiving or pretty much broken the back of this.

  • Do we really need more volunteers on an international level?

  • Number two Just who is stepping up anyway?

  • Uh, and and have we hit the kind of wall that some say this is just not something I want to respond to.

  • And third of all the holiday season, even we know internationally that providing the the international health care worker response is always challenging, particularly around the holiday season.

  • This is going to be a key one.

  • Yes, we need protective equipment.

  • Yes, we need beds.

  • We need that.

  • But in the end, the most critical resource we have today, it is still our people.

  • We know we're having other challenges.

  • This article first highlighted the possibility major food crisis is tthe e f a o and others just yesterday made comments about this very issue that under these very dire conditions in these three affected countries, we need to be mindful of.

  • We're not just providing care for people for their diseases, but also providing water and food for them in their limited ability to obtain that in terms of looking at the actual efforts.

  • This is an article from October 20th which highlighted the problems that relief efforts were slow to take off.

  • That was really at the height of when people were concerned about this transmission in a way that some would say bordered on fear.

  • But if you look even this past month, if they aid pledged and the actual age were alive, you can see the dismal kind of support that's been there, and this is one that I give our country great credit for.

  • While much of this relief was slow to get there, we were operating on program or bureaucratic time, and the virus is operating in virus time.

  • We at least, did provide the leadership position both in terms of the voice of need for support.

  • But as well as providing sports, I'm very proud of the U.

  • S.

  • For that, I asked, Where's the rest of the world where these were not the most updated numbers?

  • We still have a big gap between many of the countries of the world that could provide support.

  • And again, this is not about just humanitarian aid.

  • This is also about self interest.

  • It's very clear from the security community from the intelligence community that really Equatorial Africa really is vulnerable.

  • Thio collapse.

  • If we don't contain this Assitance, we in this country still have our own challenges.

  • Getting the kind of resource is the administration proposed a $6.2 billion emergency funding requests, which is still working its way through Congress.

  • We need to have this kind of opportunity now t do this work.

  • We can't do it on the backs of our current budgets.

  • I wrote a piece back again in September talking about this epidemic and political in which I talked about Plan A, B and C Plan A was just what we're doing.

  • Plan view is how we're gonna keep it from spreading.

  • And Plan C was how we're going to move to the future and plans.

  • He was all about vaccine, and I remain convinced that this will be an endemic disease of these countries.

  • That it doesn't spread into others does spread and others.

  • It will be even more of a challenge.

  • But in the end, we're gonna need vaccine that's going to be critical.

  • We know that there are experimental drugs and vaccines being considered.

  • We knew that early on in the outbreak, and we're very happy to say that with the vaccine issue, we may see real potential here.

  • Maybe not immediately, but it's very real that we actually can see.

  • This is the best hope for arresting Ebola.

  • I understand the challenges we have.

  • What?

  • We don't have a license toe vaccine today for evil in humans.

  • We have done substantial work in some human primates.

  • The problem is is that you're not always the best models.

  • We have insufficient clinical data assessed the compatibility between nonhuman primates and human pathogenesis and immunity, an intervention targeting host functions and drug metabolism for treatment.

  • Studies clearly may be impacted by subtle species differences.

  • So we're really in the first time trying to do this work.

  • I call it painting the moving train.

  • In the populations in West Africa, there are currently three primary vaccines under consideration.

  • One has been effectually known as the chimp adenovirus three or associated with the National Institutes of Health and GlaxoSmithKline.

  • There are two other VSC vaccines.

  • One with Newlink on now is just seeing a moment associating with Merc.

  • This was first produced by, uh, the Canadian government in license to New Link and professors that a U.

  • S company also has another VSD platform vaccine.

  • All addressing you've always a year.

  • Just several weeks ago, the U.

  • S government invested heavily in the professor's vaccine, awarding them a $5.8 million to move their vaccine forward, and yesterday a major new announcement was made.

  • We're doing three i will based company which holds the rights to the Public Health Agency of Canada.

  • Vaccine now has just signed deal with Merc, in which really loose the prospects for this vaccine moving forward.

  • We know that we're going to start vaccine trials in West African the next month.

  • Activity is already on going there.

  • This will include both the G s K chimp had no vaccine as well as the new link Merc Uh uh VSD vaccine.

  • There's much to work out with this, though.

  • However, I'm part of a group co chair a group with Chairman Jeremy Farah from, uh, the Wellcome Trust that actually has formed what it's called the Team B 27 international experts that are actually working to come up with alternative strategies and plans that can challenge our current efforts.

  • Get us the safest, most effective vaccine in Africa as soon as possible in the amounts that we need in a way that the local population will use it.

  • I just want to mention briefly there are a number of Vogler treatments understudy, also a number of therapeutic compounds, one that we have heard a lot about a Z map.

  • A triple monoclonal antibody cocktail.

  • There's Indiana body infusion.

  • I won't go into that more today to say that that has become a common response kind of thing, too.

  • Plasma free someone who's recovered and provide that nobody infusion.

  • I must add that the data are very, very unclear that there's really any clinical benefit to this yet where we continue to do it.

  • But we need more information, and then the final treatment area under consideration is Vira preparation inhibitors.

  • The first trials for Ebola treatments will start at MSs sites this next month.

  • While we recognize that primary care just floor IDs, electrolytes support are really the first line and most importantly in right now, Ebola drugs may have a potential real role in this outbreak.

  • On going It will be a challenge, of course, economically and again from a a vex or from a trump treatment efficacy in a manufacturing standpoint license sure to get these drugs in time Pair of care for this really illegal of patients.

  • We've learned clearly from the United States that with a kind of therapeutic interventions we've seen used here in people being treated the United States, we can take Ebola from being an almost always fatal disease, tau one in which it is not.

  • Ah, and I think this is an important point.

  • So we clearly will need to continue to investigate intensive care methods into themselves and that what can we do here to improve on that in the field?

  • In Africa, we have anecdotal reports suggesting aggressive approach.

  • Clinical care can improve survival rates that these air from the cases here and us targeted replay shin of fluids and electrolytes, monitoring treatment for Cole infections and even nutritional support.

  • Let me just say that I won't go into this much beyond the fact that that we all recognize and understand the challenges that we hadn't.

  • We have the first Ebola cases diagnosed in Texas and what that meant both in terms of the public's understanding of what a bowl element to this country are messaging in, how we approach that messaging on and also just how we protected our health care workers.

  • Suffice it to say on articles like this, it was not helpful that again the public health community was challenged of such about what we did.

  • But I think we did learn some valuable lessons.

  • One of them is we have to be very careful not to overstate what we know and don't know and we can still have a voice of authority about what we know and don't know.

  • On in making absolute statements which were doing today and continue to do, I think is, is ah challenge.

  • There is issues around travel and travel bans or and how we deal with health care workers I have set along.

  • We can both protect the public and treat health care workers with dignity and scientific evidence without one or the other.

  • And I think the real question is how we just do that.

  • I think the graduated monitoring system we have is actually very helpful.

  • I think we have to be careful if we have one health care worker.

  • The does transmit in this country after returning, that will be the flea on the hair on the tail of the dog, not the body of what we know.

  • But we have to understand that could fundamentally change how people perceived it.

  • So how can we accomplish both?

  • And I think we don't want health care workers to feel shunned or to feel maligned by some kind of mandatory quarantine.

  • And so I think again the graduated program we have today makes great sense.

  • We've seen people back off this Mu Natori quarantine of almost being locked in your house, and I think that's a good thing in terms of health care worker protection.

  • We had been spoken about that issue for sometimes saying that we need better protection.

  • Ondas you saw after the Dallas cases, we didn't have that.

  • CDC unveiled new peopIe guidance for Ebola back in October.

  • One of the lessons we learned here is we do not need or want 5000 hospitals able to take care of Ebola patients.

  • Every health care worker in the United States needs to be able to recognize a possible case, meaning that in fact, if someone has been in West Africa or has contact with someone who is in West Africa was ill and on.

  • And I should say during the roughly 21 day time period and presents with vomiting, diarrhea with without fever, you have thio be able to evaluate those patients safely for the workers and effectively for the patient.

  • And I think today we're much further along in this country with a system in place at each community level area to actually help health care workers identify potential patients, move them safely to a place for adequate evaluation can be done.

  • And then, if they're found, Ebola, where good medical care could be provided in health care workers.

  • 10 work safely with the level of protection they're provided in the training they have now received.

  • One of the areas I think that's gonna be a challenge is we do know that we are going to have increasing demands for protective gear.

  • Today in The Wall Street Journal, there's an article addressing that very issue about potential shortages of P p E.

  • Because of the rapid purchase by so many organizations, and this is an area we're gonna have to monitor very carefully.

  • We need to have P p e on the front lines of the battle in West Africa, and we can't run into shortages.

  • And so this is near that will require ongoing monitoring and activity of necessary.

  • We just say at the end of this meeting that I mentioned at the National Academy of Sciences to the medicine, I really did highlight a number of uncertainties.

  • Uh, the issue of airborne transmission.

  • Our group believes that it absolutely does occur potentially can occur in the patient said it met the community, setting this idea that we are not having airborne transmissions.

  • Unfortunate.

  • If you look at the idea of creating aerosols in a patient care area, if you look at projectile vomiting with diseases like Noro virus, et cetera, there's Ah lot of information would support that.

  • This is a possibility.

  • So one day, if we have to retract on, is their airborne transmission.

  • That shouldn't be one where we create a crisis.

  • And yet we've been drawing these very salad bright lines around this issue.

  • We know we have patients that advanced beyond 21 days.

  • Again, This is again what I call the flea on the hair on the tail of the dog.

  • The vast majority are going to occur within 21 days, eh?

  • So we will have ongoing questions.

  • Our group those publishing a paper on a comprehensive review on transmission in New York term, which will be ensure covered in our site.

  • And we will make that available to all of you, which really addresses many of these questions.

  • So yes, in fact, the vast majority of transmission, if not almost all of his body fluid content we can't say all of the ISS.

  • So let me just conclude by saying we're in uncharted territories and is loose, Caroline said.

  • If you don't know where you're going, any road will get you there and this is a challenge for us because in part we don't know where we're going in some cases, because conditions on the ground the future is very unpredictable and we're gonna after they basically making up our travel itinerary as we go and this is something we just have to get more comfortable.

  • And finally I conclude by just saying as evidence was crucial in said during this holiday season, are these the shadows of the things that will be or the shadows of the things that may be only And I think that we still have a lot of questions about what that will be in terms of the future with Ebola in Africa and until we have an adequate and safe that scene, which we hope is not many, many months off.

  • But it will be some months off.

  • We really are left with our primary public health and medical care practices to try to stop and reduce this particular epidemic so with that, I'll conclude, and I will go ahead and open it up to questions and any comments.

  • So one of the first questions that came in was the question.

  • Can you come into the role that Cuba's playing?

  • And just in general, any other questions that have come up as it relates Thio?

  • Other countries working in the theatre?

  • As you know, Cuba was one of the first U.

  • S renown U.

  • S.

  • Governments to actually completely staff and Ebola treatment center by themselves, and they have been there.

  • We're seeing more and more support coming in from other countries.

  • Again, the real backbone still has been the NGOs that have continued to provide really very important care, as well as a growing presence of U.

  • S.

  • A.

  • I.

  • D supported activities.

  • They're both with NGOs and just from the military built clinics.

  • Hopefully, the big issue remains just the need for health care workers, probably health workers to be there and for the ongoing intervention with the communities.

  • And it's really unclear just how working with these communities will continue the trust issues.

  • The cultural issues air really, really very critical right now.

  • The another question is agree prevention and vaccines is the most effective way to go now to a potential vaccines are developed.

  • Using the boat was I Air and the article about genomics and the characteristics of the current epidemic point to the fact that it seems to be a different strain from Zaire.

  • There is nothing that says this is a different strain in Zaire.

  • Is is I year.

  • The question is how much trained difference can occur there.

  • And we really have no evidence yet that that we really have that says that this vaccine won't work.

  • The team real indicator is going to be when we actually begin clinical trials to say that that way should in fact the vaccine will or won't protect.

  • And that will give us the answer we're looking for.

  • I'm confident at this point I think that the vaccine will work.

  • I believe that what at least one of the candidate vaccines has a very high possibility of working, But we'll see this is the question is coming in from a number of different people.

  • But you know me saying we have a lot to learn about Ebola.

  • There's no absolutes, but why do I say a travel ban is not a good idea.

  • Let me just make two points about that issue one years is that we could a CZ we learned in HIV, AIDS and foreign desires and so forth.

  • You can make all kinds of very overreaching recommendations that can try to provide 100% of safety to everyone.

  • And all I would say in that situation here is that yes, you can argue that we wouldn't worry about it in the rest of world if we could really stop all movement in and out of West Africa, which by itself is very challenging, Let me just say, because people don't have to make from these countries to fly somewhere else.

  • But number two is Look at what's happened over the past 45 days.

  • We have not seen the kind of transmission that some people worried about outside of West Africa by people traveling to or from West Africa.

  • And you know what?

  • We have potential cases arriving somewhere unsuspected in the world.

  • That's possible.

  • But we do know with the travel ban, you greatly hinder the ability to interface in West Africa, moving people in supplies in while the military is surely helping with that logistical support.

  • Right now, we still count on private aircraft on and the world's airlines to help us with that issue.

  • So to me, the trade off, I feel very confident with that.

  • We're doing the right thing.

  • And I think in the last 45 days said that this is not going to continue to be lots and lots of cases coming out of West Africa.

  • I think the U.

  • S government's follow up right now of individuals coming out of West Africa, even with direct flights O r, at least with one ticket flights meaning that they may transfer in Europe.

  • But their ticket is to the United States or another country in the Western Hemisphere, or those who haven't have broken tickets where they fly to Europe, get another ticket fly to the United States.

  • We really are picking those up, and I think that in that regard, I feel very confident that we're we're doing quite a bit about that.

  • Ah, a lot of questions here about monitoring.

  • I think most of you know right now is I just mentioned I just re emphasize it again that in fact, I believe we're capturing most if not almost all, of the individuals find out of West Africa coming to the United States.

  • State health departments are being notified Ah, by Homeland Security, working with the CDC in terms of people arriving in the individual states from some location in from West Africa, and I think the system is actually going quite well.

  • We really are able to learn of people who may have been exposed and to work with them on a daily basis at the same time.

  • Let me just say there's a sense that people who might be infected would not present themselves to medical care quickly.

  • That actually really is to me, not an issue we have demonstrated quite clearly.

  • Early medical care is a key to survival, and if you have adequate medical care, you basically increase your chances dramatically of surviving that illness.

  • So why would you not if you had your first hang you and you thought that you might actually that might be a symptom of early on steady bullet, not wanting to seek medical care very quickly.

  • So there's a real incentive here for people thio to be able to Ah, Vail Healthcare quickly and toe.

  • Wanna seek it?

  • Not want to run from.

  • So we've also had a question here If you should continue traveling to Africa.

  • We have several questions about that.

  • I would say right now if you're not in the affected countries either, uh, Sierra Leone, Guinea or Liberia or now, Molly, really.

  • The risk of the boy at this point is really no different than if you travel to any other area outside of Africa.

  • We will stay tuned to that very carefully.

  • Make sure that we know if there is evidence to spread out there.

  • But I would not change any of your travel to Ah Africa outside of these four countries right now, based on the bullet, even if you do have a need to go to one of these four countries, that would say not.

  • Do not cancel your plans.

  • But the opinion of why you're going who you might have contact with This is where you need to work closely with public health officials and those institutions on the ground in these countries To understand how you can protect yourself.

  • Uh, no.

  • The issue of Ebola terrorism it's a question has come up multiple times here too.

  • Is this a few usable or a real security issue, or is this just paranoia?

  • And let me answer this question in a way that is a bit uncomfortable for me to say.

  • I refuse to talk about Ebola terrorism in public settings from the standpoint that I think that discussing it would not be helpful in terms of the potential encouragement to occur, Uh, I think that should tell you our concerns about it and what could be done.

  • And so it's a real issue.

  • We need to be mindful of it.

  • But I think that the less said about it in terms of ah, whiter, how or why is probably better right now and just say yes.

  • We need to be really mindful of it.

  • Um, questions have come up.

  • Is there going to be sufficient participation by the community in the affected countries to participate in future clinical trials for vaccines or therapies?

  • And this is a real challenge on our

greetings and welcome to a special edition of the University of Minnesota alumni associations.

Subtitles and vocabulary

Click the word to look it up Click the word to find further inforamtion about it